|Articles|November 22, 2019
Protein A Resin to Reduce Production Cost
Author(s)Tosoh Bioscience LLC
This report details how using high capacity TOYOPEARL AF-rProtein A HC-650F resin will reduce production costs, on a per-gram produced basis.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
5
